Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Isoorientin reverses lung cancer drug resistance by promoting ferroptosis via the SIRT6/Nrf2/GPX4 signaling pathway
Senling Feng, Yuting Li, Hanhui Huang, et al.
European Journal of Pharmacology (2023) Vol. 954, pp. 175853-175853
Closed Access | Times Cited: 30

Showing 1-25 of 30 citing articles:

NRF2, a Superstar of Ferroptosis
Ruihan Yan, Bingyi Lin, Wenwei Jin, et al.
Antioxidants (2023) Vol. 12, Iss. 9, pp. 1739-1739
Open Access | Times Cited: 82
Sirt6 overexpression relieves ferroptosis and delays the progression of diabetic nephropathy via Nrf2/GPX4 pathway
Lingyu Du, Canghui Guo, Shengnan Zeng, et al.
Renal Failure (2024) Vol. 46, Iss. 2
Open Access | Times Cited: 10
Targeting ferroptosis in gastric cancer: Strategies and opportunities
Jiahan Le, Guangzhao Pan, Che Zhang, et al.
Immunological Reviews (2023) Vol. 321, Iss. 1, pp. 228-245
Closed Access | Times Cited: 20
Application of natural products in regulating ferroptosis in human diseases
Liyan Deng, Wen Tian, Lianxiang Luo
Phytomedicine (2024) Vol. 128, pp. 155384-155384
Closed Access | Times Cited: 7
Beyond Mortality: Exploring the Influence of Plant Phenolics on Modulating Ferroptosis—A Systematic Review
Nemanja Živanović, Marija Lesjak, Nataša Simin, et al.
Antioxidants (2024) Vol. 13, Iss. 3, pp. 334-334
Open Access | Times Cited: 5
New insights into crosstalk between Nrf2 pathway and ferroptosis in lung disease
Yonghu Chen, Zhe Jiang, Xuezheng Li
Cell Death and Disease (2024) Vol. 15, Iss. 11
Open Access | Times Cited: 5
Isoorientin: Unveiling the hidden flavonoid's promise in combating cancer development and progression – A comprehensive review
Lucas Fornari Laurindo, Karina Torres Pomini, Enzo Pereira de Lima, et al.
Life Sciences (2024), pp. 123280-123280
Open Access | Times Cited: 5
Inducing ferroptosis by traditional medicines: a novel approach to reverse chemoresistance in lung cancer
Yumin Wang, Jing Hu, Joshua S. Fleishman, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 4
Dual role of Nrf2 signaling in hepatocellular carcinoma: promoting development, immune evasion, and therapeutic challenges
Lin Gan, Weimin Wang, Jinxiu Jiang, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 4
Targeting ferroptosis: a promising approach for treating lung carcinoma
Ziyang Wu, Tao Zhang, Wei Zhong, et al.
Cell Death Discovery (2025) Vol. 11, Iss. 1
Open Access
The potential of natural herbal plants in the treatment and prevention of non-small cell lung cancer: An encounter between ferroptosis and mitophagy
Yujie Yang, Bing Jiang, Lijuan Shi, et al.
Journal of Ethnopharmacology (2025), pp. 119555-119555
Closed Access
Role of the sulfur-containing amino acid-ROS axis in cancer chemotherapeutic drug resistance
Bingli Wu, Yinwei Cheng, Liyan Li, et al.
Drug Resistance Updates (2025), pp. 101238-101238
Closed Access
2‐Undecanone induces ferroptosis via the STAT3/GPX4 pathway to enhance sensitivity of renal cell carcinoma to sunitinib
Zixuan Chen, Chengtao Han, Huiwen Xie, et al.
BioFactors (2025) Vol. 51, Iss. 2
Closed Access
Ferroptosis in lung cancer: dual role, multi-level regulation, and new therapeutic strategies
Yunbin Li, Xiaosong Li, Jian Li
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 3
Ferroptosis: emerging roles in lung cancer and potential implications in biological compounds
Qiuran Liang, Yuehui Wang, Yili Li, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 3
Hawthorn with “homology of medicine and food”: a review of anticancer effects and mechanisms
Ziying Zhou, Yi Nan, Xiangyang Li, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 3
ATF1 promotes ferroptosis resistance in lung cancer through enhancing mRNA stability of PROM2
Minjie Hu, Jiali Yang, Zusong Tan
Experimental Cell Research (2024) Vol. 442, Iss. 1, pp. 114190-114190
Closed Access | Times Cited: 3
Ferroptosis: Potential opportunities for natural products in cancer therapy
Anzheng Nie, Chaozan Shen, Zheng Zhou, et al.
Phytotherapy Research (2023) Vol. 38, Iss. 3, pp. 1173-1190
Closed Access | Times Cited: 9
FKBP3, a poor prognostic indicator, promotes the progression of LUAD via regulating ferroptosis and immune infiltration
Shengyi Li, Lexin Yang, Jing Li
Medicine (2024) Vol. 103, Iss. 26, pp. e38606-e38606
Open Access | Times Cited: 2
Targeting ferroptosis regulators in lung cancer: Exploring natural products
Yuhao Wang, Cheng Shenghua, Chen Jueying, et al.
Heliyon (2024) Vol. 10, Iss. 14, pp. e33934-e33934
Open Access | Times Cited: 2
Nrf2 in human cancers: biological significance and therapeutic potential
Yu Tian, Lixin Tang, Xin Wang, et al.
American Journal of Cancer Research (2024) Vol. 14, Iss. 8, pp. 3935-3961
Closed Access | Times Cited: 2
Dihydroisotanshinone I regulates ferroptosis via PI3K/AKT pathway to enhance cisplatin sensitivity in lung adenocarcinoma
Feng-jiao Li, Li-Chen Gao, Hui‐Zhi Long, et al.
Journal of Pharmacy and Pharmacology (2024)
Closed Access | Times Cited: 1
Erianin inhibits the progression of DDP-resistant lung adenocarcinoma by regulating the Wnt/β-catenin pathway and activating the caspase-3 for apoptosis in vitro and in vivo
Lingxue Tang, Yiling Ruan, Beibei Wang, et al.
Hereditas (2024) Vol. 161, Iss. 1
Open Access | Times Cited: 1
Enhancing the antioxidant potential of wheatgrass to improve nutrient value
Chuyang Wang, Meng‐Lu Wang, Qin-Quan Li, et al.
Seed Biology (2024) Vol. 3, Iss. 1
Closed Access
Emerging role of sirtuins in non‑small cell lung cancer (Review)
Min Zhou, Wei Lin, Renfu Lu
Oncology Reports (2024) Vol. 52, Iss. 4
Closed Access
Page 1 - Next Page

Scroll to top